blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1638947

EP1638947 - TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE-1 [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.06.2011
Database last updated on 07.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[2010/10]
Former [2006/13]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue Rahway
New Jersey 07065-0907 / US
Inventor(s)01 / WADDELL, Sherman, T.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
02 / SANTORELLI, Gina, M.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
03 / MALETIC, Milana, M.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
04 / LEEMAN, Aaron, H.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
05 / GU, Xin
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
06 / GRAHAM, Donald, W.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
07 / BALKOVEC, James, M.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
08 / ASTER, Susan, D.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
 [2006/13]
Representative(s)Horgan, James Michael Frederic, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2006/48]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Former [2006/13]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date04753355.926.05.2004
[2006/13]
WO2004US16512
Priority number, dateUS20030474042P29.05.2003         Original published format: US 474042 P
[2006/13]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004106294
Date:09.12.2004
Language:EN
[2004/50]
Type: A2 Application without search report 
No.:EP1638947
Date:29.03.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 09.12.2004 takes the place of the publication of the European patent application.
[2006/13]
Type: B1 Patent specification 
No.:EP1638947
Date:04.08.2010
Language:EN
[2010/31]
Search report(s)International search report - published on:US17.03.2005
(Supplementary) European search report - dispatched on:EP28.09.2007
ClassificationIPC:C07D249/08, C07D249/16, A61K31/4196, C07D249/12, C07D487/04, A61P3/06, A61P3/10, A61P5/24, A61P5/46, A61P9/10
[2007/44]
CPC:
C07D249/08 (EP,US); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P43/00 (EP); A61P5/24 (EP);
A61P5/46 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07D249/16 (EP,US); C07D413/08 (EP,US); C07D487/04 (EP,US) (-)
Former IPC [2006/13]C07D249/08, C07D249/16, A61K31/4196
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/13]
Extension statesALNot yet paid
HRNot yet paid
LT29.12.2005
LV29.12.2005
MKNot yet paid
TitleGerman:TRIAZOLDERIVATE ALS INHIBITOREN VON 11-BETA- HYDROXYSTEROID-DEHYDROGENASE-1[2006/13]
English:TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE-1[2006/13]
French:DERIVES DE TRIAZOLE UTILES COMME INHIBITEURS DE LA 11-BETA HYDROXYSTEROIDE DESHYDROGENASE-1[2006/13]
Entry into regional phase29.12.2005National basic fee paid 
29.12.2005Search fee paid 
29.12.2005Designation fee(s) paid 
29.12.2005Examination fee paid 
Examination procedure29.12.2005Examination requested  [2006/13]
03.04.2008Despatch of a communication from the examining division (Time limit: M04)
05.08.2008Reply to a communication from the examining division
15.02.2010Communication of intention to grant the patent
21.06.2010Fee for grant paid
21.06.2010Fee for publishing/printing paid
Opposition(s)06.05.2011No opposition filed within time limit [2011/28]
Fees paidRenewal fee
27.03.2006Renewal fee patent year 03
07.05.2007Renewal fee patent year 04
18.03.2008Renewal fee patent year 05
02.06.2009Renewal fee patent year 06
31.03.2010Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
HU04.08.2010
IT04.08.2010
NL04.08.2010
PL04.08.2010
RO04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
TR04.08.2010
BG04.11.2010
GR05.11.2010
ES15.11.2010
PT06.12.2010
[2013/45]
Former [2013/44]AT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
IT04.08.2010
NL04.08.2010
PL04.08.2010
RO04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
TR04.08.2010
BG04.11.2010
GR05.11.2010
ES15.11.2010
PT06.12.2010
Former [2011/32]AT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
IT04.08.2010
NL04.08.2010
PL04.08.2010
RO04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
BG04.11.2010
GR05.11.2010
ES15.11.2010
PT06.12.2010
Former [2011/23]AT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
NL04.08.2010
PL04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
BG04.11.2010
GR05.11.2010
PT06.12.2010
Former [2011/19]AT04.08.2010
BE04.08.2010
CY04.08.2010
DK04.08.2010
FI04.08.2010
NL04.08.2010
PL04.08.2010
SE04.08.2010
SI04.08.2010
BG04.11.2010
GR05.11.2010
PT06.12.2010
Former [2011/17]AT04.08.2010
BE04.08.2010
CY04.08.2010
FI04.08.2010
NL04.08.2010
PL04.08.2010
SE04.08.2010
SI04.08.2010
BG04.11.2010
GR05.11.2010
PT06.12.2010
Former [2011/15]AT04.08.2010
CY04.08.2010
FI04.08.2010
NL04.08.2010
PL04.08.2010
SE04.08.2010
SI04.08.2010
BG04.11.2010
GR05.11.2010
PT06.12.2010
Former [2011/13]AT04.08.2010
CY04.08.2010
FI04.08.2010
NL04.08.2010
PL04.08.2010
SI04.08.2010
BG04.11.2010
PT06.12.2010
Former [2011/11]AT04.08.2010
FI04.08.2010
NL04.08.2010
PL04.08.2010
SI04.08.2010
BG04.11.2010
PT06.12.2010
Former [2011/08]AT04.08.2010
NL04.08.2010
Documents cited:Search[A]WO0190092  (BIOVITRUM AB [SE], et al) [A] 1-15 * see chemical structure of the compounds of claim 1 and their activity on 11-beta hydroxysteroid dehydrogenase I *;
 [PX]WO03065983  (MERCK & CO INC [US], et al) [PX] 1-15 * see compounds of claim 1 and their activity on 11-beta hydroxysteroid dehydrogenase I *;
 [E]EP1790641  (ASTELLAS PHARMA INC [JP]) [E] 1-15* see defintions in claim 1 and activity on 11-beta hydroxysteroid dehydrogenase I *
International searchJP2002201193  [ ] (TAKEDA CHEMICAL INDUSTRIES LTD);
 [A]  - CAPLUS, Database accession no. 2002:533193, XP002984089
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.